Mechanism for increased bioavailability of tacrine in fasted rats

Jong Hyuk Sung, Soon Sun Hong, Sung Hoon Ahn, Hong Li, Seung Yong Seo, Chul Hong Park, Byung Soon Park, Suk Jae Chung

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The mechanism associated with the increased bioavailability of tacrine as a result of a 24-h period of fasting was examined in rats. The AUC value for tacrine after the fasting was 52% higher compared with normal feeding when 4 mg kg-1 of tacrine was orally administered, but the value for velnacrine, a hydroxylated metabolite of tacrine, was reduced by 10%. The relative metabolic ratio of tacrine in urinary excretion (Autacrine divided by Auvelnacrine) was lower in fasted rats compared with normally fed rats. This clearly shows that metabolism of tacrine is reduced with 24-h fasting after oral administration. Altered intestinal permeation in the fasting state was hypothesized, and the transport of tacrine across the rat intestine was studied. When a fasted intestine was mounted in an Ussing chamber, the mucosalto-serosal permeability of tacrine was increased to double that for a fed rat intestine. To examine the effect of absorption rate on the hepatic metabolism of tacrine, a direct pyloric vein infusion study was carried out. Compared with an infusion of tacrine for 5 min, a slow infusion of tacrine over a period of 30 or 60 min increased the hepatic metabolism of tacrine and decreased its systemic clearance in rats. Collectively, these results suggest that rapid transport across the intestine aids tacrine in avoiding hepatic first-pass metabolism and enhances its bioavailability in fasted rats. From these findings, we conclude that both oral administration before a meal and a reduction in the dose might be recommended in tacrine therapy considering the serious hepatotoxicity of tacrine in clinical use.

Original languageEnglish
Pages (from-to)643-649
Number of pages7
JournalJournal of Pharmacy and Pharmacology
Volume58
Issue number5
DOIs
Publication statusPublished - 2006 May 1

Fingerprint

Tacrine
Biological Availability
Intestines
Fasting
Oral Administration
Liver

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

Sung, J. H., Hong, S. S., Ahn, S. H., Li, H., Seo, S. Y., Park, C. H., ... Chung, S. J. (2006). Mechanism for increased bioavailability of tacrine in fasted rats. Journal of Pharmacy and Pharmacology, 58(5), 643-649. https://doi.org/10.1211/jpp.58.5.0009
Sung, Jong Hyuk ; Hong, Soon Sun ; Ahn, Sung Hoon ; Li, Hong ; Seo, Seung Yong ; Park, Chul Hong ; Park, Byung Soon ; Chung, Suk Jae. / Mechanism for increased bioavailability of tacrine in fasted rats. In: Journal of Pharmacy and Pharmacology. 2006 ; Vol. 58, No. 5. pp. 643-649.
@article{afde04844c8d49828acad99c4cf7d5e1,
title = "Mechanism for increased bioavailability of tacrine in fasted rats",
abstract = "The mechanism associated with the increased bioavailability of tacrine as a result of a 24-h period of fasting was examined in rats. The AUC value for tacrine after the fasting was 52{\%} higher compared with normal feeding when 4 mg kg-1 of tacrine was orally administered, but the value for velnacrine, a hydroxylated metabolite of tacrine, was reduced by 10{\%}. The relative metabolic ratio of tacrine in urinary excretion (Autacrine divided by Auvelnacrine) was lower in fasted rats compared with normally fed rats. This clearly shows that metabolism of tacrine is reduced with 24-h fasting after oral administration. Altered intestinal permeation in the fasting state was hypothesized, and the transport of tacrine across the rat intestine was studied. When a fasted intestine was mounted in an Ussing chamber, the mucosalto-serosal permeability of tacrine was increased to double that for a fed rat intestine. To examine the effect of absorption rate on the hepatic metabolism of tacrine, a direct pyloric vein infusion study was carried out. Compared with an infusion of tacrine for 5 min, a slow infusion of tacrine over a period of 30 or 60 min increased the hepatic metabolism of tacrine and decreased its systemic clearance in rats. Collectively, these results suggest that rapid transport across the intestine aids tacrine in avoiding hepatic first-pass metabolism and enhances its bioavailability in fasted rats. From these findings, we conclude that both oral administration before a meal and a reduction in the dose might be recommended in tacrine therapy considering the serious hepatotoxicity of tacrine in clinical use.",
author = "Sung, {Jong Hyuk} and Hong, {Soon Sun} and Ahn, {Sung Hoon} and Hong Li and Seo, {Seung Yong} and Park, {Chul Hong} and Park, {Byung Soon} and Chung, {Suk Jae}",
year = "2006",
month = "5",
day = "1",
doi = "10.1211/jpp.58.5.0009",
language = "English",
volume = "58",
pages = "643--649",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "5",

}

Sung, JH, Hong, SS, Ahn, SH, Li, H, Seo, SY, Park, CH, Park, BS & Chung, SJ 2006, 'Mechanism for increased bioavailability of tacrine in fasted rats', Journal of Pharmacy and Pharmacology, vol. 58, no. 5, pp. 643-649. https://doi.org/10.1211/jpp.58.5.0009

Mechanism for increased bioavailability of tacrine in fasted rats. / Sung, Jong Hyuk; Hong, Soon Sun; Ahn, Sung Hoon; Li, Hong; Seo, Seung Yong; Park, Chul Hong; Park, Byung Soon; Chung, Suk Jae.

In: Journal of Pharmacy and Pharmacology, Vol. 58, No. 5, 01.05.2006, p. 643-649.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mechanism for increased bioavailability of tacrine in fasted rats

AU - Sung, Jong Hyuk

AU - Hong, Soon Sun

AU - Ahn, Sung Hoon

AU - Li, Hong

AU - Seo, Seung Yong

AU - Park, Chul Hong

AU - Park, Byung Soon

AU - Chung, Suk Jae

PY - 2006/5/1

Y1 - 2006/5/1

N2 - The mechanism associated with the increased bioavailability of tacrine as a result of a 24-h period of fasting was examined in rats. The AUC value for tacrine after the fasting was 52% higher compared with normal feeding when 4 mg kg-1 of tacrine was orally administered, but the value for velnacrine, a hydroxylated metabolite of tacrine, was reduced by 10%. The relative metabolic ratio of tacrine in urinary excretion (Autacrine divided by Auvelnacrine) was lower in fasted rats compared with normally fed rats. This clearly shows that metabolism of tacrine is reduced with 24-h fasting after oral administration. Altered intestinal permeation in the fasting state was hypothesized, and the transport of tacrine across the rat intestine was studied. When a fasted intestine was mounted in an Ussing chamber, the mucosalto-serosal permeability of tacrine was increased to double that for a fed rat intestine. To examine the effect of absorption rate on the hepatic metabolism of tacrine, a direct pyloric vein infusion study was carried out. Compared with an infusion of tacrine for 5 min, a slow infusion of tacrine over a period of 30 or 60 min increased the hepatic metabolism of tacrine and decreased its systemic clearance in rats. Collectively, these results suggest that rapid transport across the intestine aids tacrine in avoiding hepatic first-pass metabolism and enhances its bioavailability in fasted rats. From these findings, we conclude that both oral administration before a meal and a reduction in the dose might be recommended in tacrine therapy considering the serious hepatotoxicity of tacrine in clinical use.

AB - The mechanism associated with the increased bioavailability of tacrine as a result of a 24-h period of fasting was examined in rats. The AUC value for tacrine after the fasting was 52% higher compared with normal feeding when 4 mg kg-1 of tacrine was orally administered, but the value for velnacrine, a hydroxylated metabolite of tacrine, was reduced by 10%. The relative metabolic ratio of tacrine in urinary excretion (Autacrine divided by Auvelnacrine) was lower in fasted rats compared with normally fed rats. This clearly shows that metabolism of tacrine is reduced with 24-h fasting after oral administration. Altered intestinal permeation in the fasting state was hypothesized, and the transport of tacrine across the rat intestine was studied. When a fasted intestine was mounted in an Ussing chamber, the mucosalto-serosal permeability of tacrine was increased to double that for a fed rat intestine. To examine the effect of absorption rate on the hepatic metabolism of tacrine, a direct pyloric vein infusion study was carried out. Compared with an infusion of tacrine for 5 min, a slow infusion of tacrine over a period of 30 or 60 min increased the hepatic metabolism of tacrine and decreased its systemic clearance in rats. Collectively, these results suggest that rapid transport across the intestine aids tacrine in avoiding hepatic first-pass metabolism and enhances its bioavailability in fasted rats. From these findings, we conclude that both oral administration before a meal and a reduction in the dose might be recommended in tacrine therapy considering the serious hepatotoxicity of tacrine in clinical use.

UR - http://www.scopus.com/inward/record.url?scp=33646456460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646456460&partnerID=8YFLogxK

U2 - 10.1211/jpp.58.5.0009

DO - 10.1211/jpp.58.5.0009

M3 - Article

C2 - 16640833

AN - SCOPUS:33646456460

VL - 58

SP - 643

EP - 649

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 5

ER -